SEC Form 4 · accession 0001477932-15-007696
Innovation Pharmaceuticals Inc. · IPIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Krishna Menon
Officer — President and CSO · Director · 10% Owner
Period of report
Nov 30, 2015
Accepted (ET)
Dec 18, 2015 · 12:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001355250
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 30, 2015 | J | 6,000,000 | $0.00 | D | 15,048,286 | I | Trustee for the Menon Family Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) | $0.11 | Dec 29, 2010 | A | 6,000,000 | A | Dec 29, 2010 | Dec 30, 2020 | Common | 6,000,000 | 6,000,000 | D |
| Stock Option (right to buy) | $0.11 | Dec 29, 2010 | A | 6,000,000 | A | Jun 30, 2011 | Dec 29, 2020 | Common | 6,000,000 | 12,000,000 | D |
| Stock Option (right to buy) | $0.11 | Dec 29, 2010 | A | 6,000,000 | A | Jan 3, 2012 | Dec 30, 2020 | Common | 6,000,000 | 18,000,000 | D |
Explanation of responses
- F1Krishna Menon is the Trustee for the Menon Family Trust.
Remarks
Represents shares transferred to a non-related third party in a non-cash transaction pursuant to a Settlement Agreement.